Sunanda V. Kane MD, MSPHProfessor of Medicine, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota
Sunanda V. Kane completed a medical degree at Rush Medical College in Chicago, Illinois. Her postdoctoral training included an internship and residency in internal medicine at Rush-Presbyterian-St. Luke’s Medical Center and a fellowship in the Section of Gastroenterology at the University of Chicago. Prior to joining the staff at Mayo Clinic College of Medicine, Dr. Kane was Associate Professor of Medicine at the University of Chicago.
Dr. Kane is a member and Fellow of several professional organizations, including the American College of Physicians, the American Gastroenterological Association (AGA), and the American College of Gastroenterology (ACG). Dr. Kane holds key positions on several advisory bodies. She was Chair of the ACG Women’s Committee and is currently a member of the ACG Board of Trustees and is the Director of the ACG Quality Council. She was also the Chair of the CCFA Patient Education Committee. She also is on the GI Safety Advisory Committee for the FDA.
Dr. Kane was the Editor for Pocket Guide to Inflammatory Bowel Diseases (2005) as well as Practical Gastroenterology and Hepatology (2010). She has written the “AGA Guide to Self-Management of IBD”, a book written specifically for patients with IBD. She has published over 110 articles and reviews in the peer-reviewed literature, and she is an invited reviewer for multiple medical journals. She is the first female Associate Editor of Alimentary Pharmacology and Therapeutics. Dr. Kane is a frequent invited lecturer on topics relating to the care and management of patients with inflammatory bowel disease.
Recent Contributions to PracticeUpdate:
- Cumulative Exposure to Immunomodulators and Biologics and the Risk of Cervical Neoplasia in Women With IBD
- Depressive Symptoms Predict Clinical Recurrence of IBD
- Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease on Combination Therapy
- Ileal or Colonic Histologic Activity Is Not Associated With Clinical Relapse in Patients With Crohn’s Disease in Endoscopic Remission
- Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases
- Long-Term Oral Contraceptive Use and Risk of Crohn's Disease Complications
- Low Risk of Birth Defects in Infants Whose Mothers Are Treated With Anti-TNF Agents During Pregnancy
- Successful In Vitro Fertilization in Women With Inflammatory Bowel Disease
- Association of Inflammatory Bowel Disease and Cervical Neoplasia
- Mechanisms of Fibrosis in Crohn's Disease